ALAB Form 4/A: Insider Sales, Gifts and Reporting Correction
Rhea-AI Filing Summary
Astera Labs insider amendment reports multiple disposals and gifts of common stock by Michael Truett Tate, the companys CFO and trustee of the Tate Trust. The Form 4/A shows sales on 08/07/2025 and 08/08/2025: reported disposals include 43,184, 7,550, 15,141, and 34,125 shares sold at weighted-average prices ranging roughly from $169.05 to $174.04. The filing also records two bona fide gifts of 7,500 and 10,000 shares to non-affiliated recipients. Following the reported transactions the filing shows 501,496 shares beneficially owned indirectly by the Tate Trust. The amendment clarifies that a previously reported acquisition by GlobalStar Donor Advised Fund was an administrative error and that the Reporting Person has no pecuniary interest in that fund.
Positive
- Amendment corrected a prior reporting error regarding GlobalStar Donor Advised Fund, improving disclosure accuracy
- Detailed footnotes provide weighted-average price ranges and offer to supply per-trade breakdowns, enhancing transparency
- Gifts reported as bona fide to non-affiliated recipients, with explicit disclosure of nature of transfers
Negative
- Material insider sales totaling 100,000 shares on 08/07/2025 at prices roughly $169$174, which may be viewed negatively by some investors
- Significant reduction in beneficial ownership to 501,496 shares indirectly held by the Tate Trust after transactions
Insights
TL;DR: CFO executed sizable open-market sales and gifts; amendment corrects a prior reporting error.
The filing documents open-market disposals totaling 100,000 shares sold across multiple transactions on 08/07/2025 at weighted-average prices in the approximately $169$174 range, plus gifts of 7,500 and 10,000 shares to non-affiliated recipients. The shares remain reported as indirectly owned via the Tate 1997 Living Trust, with 501,496 shares retained post-transactions. From a market-impact perspective, the sales are material on a transaction basis but the filing does not include company financials or context for the disposals, limiting conclusions about motive or valuation impact.
TL;DR: Amendment improves disclosure accuracy; gifts and sales were reported with required detail.
The Form 4/A corrects an earlier misreport of a 7,500-share acquisition by a donor-advised fund, clarifying the Reporting Person has no pecuniary interest in that fund. The filing identifies the Reporting Person as CFO and trustee of the Tate Trust and discloses indirect ownership and nature of gifts, which aligns with Section 16 reporting expectations. The amendment and footnotes provide transaction ranges and an offer to supply per-price breakdowns, supporting transparency for compliance review.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 10,000 | $0.00 | -- |
| Sale | Common Stock | 43,184 | $169.608 | $7.32M |
| Sale | Common Stock | 7,550 | $170.3396 | $1.29M |
| Sale | Common Stock | 15,141 | $171.4778 | $2.60M |
| Sale | Common Stock | 34,125 | $173.8234 | $5.93M |
| Gift | Common Stock | 7,500 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.0500 to $169.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $170.0500 to $170.8600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $171.0800 to $171.8500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.5950 to $174.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Represents a bona fide gift of shares to a non-affiliated entity. Represents a bona fide gift of shares to a non-affiliated person.
